Cleared Traditional

K770521 - ELECTROCARDIOGRAPHIC ELECTRODES, DISP.

K770521 is an FDA 510(k) clearance for ELECTROCARDIOGRAPHIC ELECTRODES, manufactured by Dobre, Inc.. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Traditional 510(k) pathway after a 11-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1977
Decision
11d
Days
Class 2
Risk

K770521 is an FDA 510(k) clearance for the ELECTROCARDIOGRAPHIC ELECTRODES, DISP.. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Dobre, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 29, 1977 after a review of 11 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dobre, Inc. devices

FDA 510(k) Submission Details - K770521

510(k) Number K770521 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1977
Decision Date March 29, 1977
Days to Decision 11 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
114d faster than avg
Panel avg: 125d · This submission: 11d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 195
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K770521.
ELECTRODE, DEIP.
K781163 · Datascope Corp. · Sep 1978
SELF-RETAINING ELECTRODE SER. #4000-100
K780908 · Andover Medical, Inc. · Jun 1978
ECG CLUSTER ELECTRODE
K771776 · C.R. Bard, Inc. · Nov 1977
LIFEPATCH TM ECG ELECTRODE
K770083 · Physio-Control Corp. · Feb 1977
RADIO TRANSPARENT ECG ELECTRODE
K761249 · Concept, Inc. · Dec 1976
ELECTRODE SERIES 1401
K760280 · Andover Medical, Inc. · Aug 1976